meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Insulin resistance
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Insulin resistance is a complex pathophysiological condition characterized by reduced sensitivity to insulin action, and it plays a crucial role in the development and progression of metabolic diseases
Insulin resistance is the primary pathophysiology underlying metabolic syndrome and type 2 diabetes
Mild inflammation has been linked to insulin resistance
Scheithauer et al. 2020 Front. Immunol. 11: 571731
A state in which [insulin](brain://8ugsw-X9_…
References (Sources)
- Abdominal obesity and metabolic syndrome
- Colonic pro-inflammatory macrophages cause insulin resistance in an intestinal Ccl2/Ccr2-dependent manner
- Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells
- New drug targets for type 2 diabetes and the metabolic syndrome
- p-Cresyl sulfate promotes insulin resistance associated with CKD
- Pathogenesis and pathophysiology of the cardiometabolic syndrome
- The crucial role and mechanism of insulin resistance in metabolic disease